查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446779

睡眠呼吸中止症診斷系統市場：依產品類型、最終用戶、地區（北美、歐洲、亞太地區、拉丁美洲、中東非洲）：全球產業分析、規模、佔有率、成長、趨勢、預測 2023-2030 年

Sleep Apnea Diagnostic Systems Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 324 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究對全球睡眠呼吸中止症診斷系統市場進行了全面分析，提供了有關市場動態、成長動力/挑戰和新興趨勢的寶貴見解。 該報告提供了預測 2023 年至 2030 年市場軌蹟的獨家數據和統計數據。

全球睡眠呼吸中止症診斷系統市場預計複合年增長率為 7%，從 2023 年的 39 億美元增加到 2030 年底的 63 億美元。

關鍵見解

  • 睡眠呼吸中止症診斷系統市場規模（2023 年）：美國：39 億美元
  • 預測市場價值（2030 年）：63 億美元
  • 全球市場成長率（2023-2030 年複合年增長率）：7.0%
  • 過去的市場成長率（2018-2022 年複合年增長率）：4.9%

睡眠呼吸中止症診斷系統市場：調查範圍

睡眠呼吸中止症診斷系統市場由一系列診斷工具和設備組成，這些工具和設備對於識別與睡眠相關的呼吸障礙（例如阻塞性睡眠呼吸中止症）非常重要。 這些系統包括多導睡眠監測儀、居家睡眠呼吸中止症測試套件和相關配件。 市場成長的主要驅動力是睡眠呼吸中止症盛行率的上升、人們對其健康影響的認識不斷提高以及診斷技術的進步。 此外，由於其便利性和成本效益，家庭睡眠測試設備的日益普及也支持了市場的擴張。

市場驅動因素：

由於肥胖、久坐的生活方式和人口老化等因素，全球範圍內睡眠呼吸中止症的盛行率持續上升。 這種流行，加上醫療保健專業人員和患者意識的不斷提高，正在推動對診斷系統的需求。 睡眠呼吸中止症診斷設備的技術進步，例如便攜式監測系統和基於雲端的數據分析，正在提高診斷準確性和患者舒適度，進一步推動市場成長。

市場限制因素：

儘管存在巨大的成長機會，睡眠呼吸中止症診斷系統市場仍面臨與報銷政策相關的挑戰，尤其是在新興國家。 農村地區獲得醫療設施和診斷服務的機會有限也阻礙了市場成長。 此外，與診斷設備相關的解釋的高成本和複雜性阻礙了市場滲透，特別是在新興市場。

市場機會：

由於技術創新和對家庭睡眠測試的日益重視，睡眠呼吸中止症診斷系統市場提供了利潤豐厚的機會。 將人工智慧 (AI) 和機器學習演算法整合到診斷設備中，可以自動分析和解釋睡眠數據，從而促進早期檢測和個人化治療策略。 此外，設備製造商和醫療保健提供者之間合作開發適合特定市場需求的經濟實惠的診斷解決方案將為市場擴張鋪平道路。

本報告涵蓋的主要問題

  • 哪些地區最有可能引入睡眠呼吸中止症診斷系統？
  • 哪些因素會影響病人對居家睡眠檢驗與實驗室多導睡眠圖的偏好？
  • 科技進步如何改變睡眠呼吸中止症診斷系統市場的競爭格局？
  • 推動睡眠呼吸中止症診斷系統領域技術創新和市場拓展的主要公司有哪些？
  • 全球睡眠呼吸中止症診斷系統市場的新趨勢和未來前景如何？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 作業
    • 主要趨勢
  • 產品類型生命週期分析
  • 睡眠呼吸中止症診斷系統市場：價值鏈
    • 原料供應商名單
    • 製造商列表
    • 銷售代理商名單
    • 申請列表
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：對市場的影響
  • 宏觀經濟因素
    • 世界產業展望
    • 世界 GDP 成長率展望
    • 全球母公司市場概覽
  • 預測因子 - 相關性和影響
  • 監管與科技環境

第三章全球睡眠呼吸中止症候群診斷系統市場展望：過去（2018-2022年）與預測（2023-2030年）

  • 主要亮點
    • 市場容量（單位）預測
    • 市場規模及年成長率
    • 絕對的貨幣機會
  • 市場規模（百萬美元）分析與預測
    • 過去的市場規模分析，2013-2016 年
    • 2018-2026 年目前市場規模預測
  • 全球睡眠呼吸中止症診斷系統市場前景：產品類型
    • 簡介/主要發現
    • 2018-2022 年按產品類型劃分的歷史市場規模（百萬美元）和銷售量（單位）分析
    • 2023-2030 年按產品類型劃分的當前市場規模（百萬美元）和銷售（單位）預測
      • 多導睡眠圖 (PSG) 設備
      • 門診PSG監測裝置
      • 臨床PSG監測裝置
      • 睡眠呼吸中止症篩檢裝置
      • 鼻流居家護理套裝
      • 週邊微血管血氧飽和度 (SPO2)
      • 體動監測裝置
  • 市場吸引力分析：產品類型
  • 全球睡眠呼吸中止症診斷系統市場前景：最終用戶
    • 簡介/主要發現
    • 2018-2022 年最終用戶過去的市場規模（百萬美元）和數量（單位）分析
    • 2023-2030 年最終用戶的當前市場規模（百萬美元）和預測銷售（單位）
      • 居家照護環境
      • 醫院
      • 睡眠中心和診所
  • 市場吸引力分析：最終用戶

第 4 章全球睡眠呼吸中止症候群診斷系統市場前景：地區

  • 主要亮點
  • 2018-2022 年按地區歷史市場規模（百萬美元）及銷售量（單位）分析
  • 2023-2030 年按地區劃分的當前市場規模（百萬美元）和預測銷售（單位）
    • 北美
    • 歐洲
    • 東亞
    • 南亞和太平洋地區
    • 拉丁美洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：地區

第五章北美睡眠呼吸中止症候群診斷系統市場展望：過去（2018-2022年）與預測（2023-2030年）

  • 主要亮點
  • 價格分析
  • 2018-2022 年過去的市場規模（10,000 美元）和銷售量（單位）分析（按市場劃分）
    • 依國家/地區
      • 美國
      • 加拿大
    • 依產品類型
    • 按最終用戶
  • 市場吸引力分析

第6章歐洲睡眠呼吸中止症候群診斷系統市場展望：過去（2018-2022年）與預測（2023-2030年）

  • 主要亮點
  • 價格分析
  • 2018-2022 年過去的市場規模（10,000 美元）和銷售量（單位）分析（按市場劃分）
    • 依國家/地區
      • 德國
      • 法國
      • 英國
      • 義大利
      • 西班牙
      • 俄羅斯
      • 土耳其
      • 歐洲其他地區
    • 依產品類型
    • 按最終用戶
  • 市場吸引力分析

第七章東亞睡眠呼吸中止症診斷系統市場展望：過去（2018-2022年）與預測（2023-2030年）

  • 主要亮點
  • 價格分析
  • 2018-2022 年過去的市場規模（10,000 美元）和市場銷售（單位）分析
    • 依國家/地區
      • 中國
      • 日本
      • 韓國
    • 依產品類型
    • 按最終用戶
  • 市場吸引力分析

第8章南亞與大洋洲睡眠呼吸中止症候群診斷系統市場前景：過去（2018-2022年）與預測（2023-2030年）

  • 主要亮點
  • 價格分析
  • 2018-2022 年過去的市場規模（10,000 美元）和市場銷售（單位）分析
    • 依國家/地區
      • 印度
      • 東南亞
      • 紐西蘭
      • 南亞和大洋洲其他地區
    • 依產品類型
    • 按最終用戶
  • 市場吸引力分析

第9章拉丁美洲睡眠呼吸中止症候群診斷系統市場展望：過去（2018-2022年）與預測（2023-2030年）

  • 主要亮點
  • 價格分析
  • 2018-2022 年過去的市場規模（10,000 美元）和市場銷售（單位）分析
    • 依國家/地區
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區
    • 依產品類型
    • 按最終用戶
  • 市場吸引力分析

第十一章競爭態勢

  • 2022 年市佔率分析
  • 市場結構
    • 依市場繪製競爭強度圖
    • 具有競爭力的便攜式 PSG 監測設備
    • 表觀產品產能
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Koninklijke Philips NV
    • Becton, Dickinson and Company
    • Braedon Medical Corporation
    • Advanced Brain Monitoring Inc.
    • SOMNOmedics GmbH
    • ResMed Inc.
    • BMC Medical Co. Ltd.
    • Natus Medical Incorporated
    • MGC Diagnostics Corporation
    • Cleveland Medical Devices Inc.

第12章附錄

  • 調查方法
  • 研究假設
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP33725

Persistence Market Research presents a comprehensive analysis of the global Sleep Apnea Diagnostic Systems Market, offering valuable insights into market dynamics, growth drivers, challenges, and emerging trends. This report delivers exclusive data and statistics projecting the market's trajectory from 2023 to 2030.

The global sleep apnea diagnostic systems market is forecast to expand at a CAGR of 7% and thereby increase from a value of US$3.9 Bn in 2023, to US$6.3 Bn by the end of 2030..

Key Insights:

  • Sleep Apnea Diagnostic Systems Market Size (2023E): US$3.9 Billion
  • Projected Market Value (2030F): US$6.3 Billion
  • Global Market Growth Rate (CAGR 2023 to 2030): 7.0%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 4.9%

Sleep Apnea Diagnostic Systems Market - Report Scope:

The Sleep Apnea Diagnostic Systems Market comprises a range of diagnostic tools and equipment crucial for identifying sleep-related breathing disorders such as obstructive sleep apnea. These systems include polysomnography devices, home sleep apnea testing kits, and related accessories. Market growth is primarily driven by the rising prevalence of sleep apnea, increasing awareness about its health implications, and advancements in diagnostic technologies. Additionally, the growing adoption of home sleep testing devices due to their convenience and cost-effectiveness fuels market expansion.

Market Growth Drivers:

The prevalence of sleep apnea continues to rise globally, propelled by factors such as obesity, sedentary lifestyles, and aging populations. This prevalence, coupled with increased awareness among healthcare professionals and patients, drives the demand for diagnostic systems. Technological advancements in sleep apnea diagnostic devices, such as portable monitoring systems and cloud-based data analytics, enhance diagnostic accuracy and patient comfort, further boosting market growth.

Market Restraints:

Despite significant growth opportunities, the Sleep Apnea Diagnostic Systems Market faces challenges related to reimbursement policies, particularly in emerging economies. Limited access to healthcare facilities and diagnostic services in rural areas also impedes market growth. Moreover, the high cost associated with diagnostic equipment and the complexity of interpretation hinder market penetration, especially in developing regions.

Market Opportunities:

The Sleep Apnea Diagnostic Systems Market offers lucrative opportunities driven by technological innovations and increasing emphasis on home-based sleep testing. Integration of artificial intelligence (AI) and machine learning algorithms in diagnostic devices enables automated analysis and interpretation of sleep data, facilitating early detection and personalized treatment strategies. Additionally, collaborations between device manufacturers and healthcare providers to develop affordable diagnostic solutions tailored to specific market needs create avenues for market expansion.

Key Questions Answered in the Report:

  • Which regions are likely to witness the highest adoption of sleep apnea diagnostic systems?
  • What factors influence patient preferences for home sleep testing versus in-laboratory polysomnography?
  • How are technological advancements reshaping the competitive landscape of the sleep apnea diagnostic systems market?
  • Who are the key players driving innovation and market expansion in the sleep apnea diagnostic systems segment?
  • What are the emerging trends and future prospects in the global sleep apnea diagnostic systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Sleep Apnea Diagnostic Systems Market, including Koninklijke Philips N.V., Becton, Dickinson and Company, Braedon Medical Corporation, and Advanced Brain Monitoring Inc., focus on product innovation and strategic collaborations to maintain market leadership. These companies invest in research and development to introduce advanced diagnostic solutions, expand their product portfolios, and gain a competitive edge. Partnerships with healthcare providers, sleep clinics, and telemedicine platforms enhance market reach and customer engagement. Moreover, investments in marketing initiatives and patient education programs contribute to market growth and brand loyalty.

Key Companies Profiled:

  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Braedon Medical Corporation
  • Advanced Brain Monitoring Inc.
  • SOMNOmedics GmbH
  • ResMed Inc.
  • BMC Medical Co. Ltd.
  • Natus Medical Incorporated
  • MGC Diagnostics Corporation
  • Cleveland Medical Devices Inc.

Sleep Apnea Diagnostic Systems Market Research Segmentation:

The Sleep Apnea Diagnostic Systems Market is segmented based on the type of diagnostic systems and geographical regions.

By Product Type:

  • Polysomnography (PSG) Devices
  • Ambulatory PSG Monitoring Devices
  • Clinical PSG Monitoring Devices
  • Sleep Apnea Screening Device
  • Nasal Flow Sensors
  • Peripheral Capillary Oxygen Saturation (SPO2)
  • Actigraphy Monitoring Devices

By End-use:

  • Home Care Settings
  • Hospitals
  • Sleep Centers & Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Sleep Apnea Diagnostic Systems Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Type Lifecycle Analysis
  • 2.4. Sleep Apnea Diagnostic Systems Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global Sleep Apnea Diagnostic Systems Market Outlook: Product Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
      • 3.3.3.1. Polysomnography (PSG) Devices
      • 3.3.3.2. Ambulatory PSG Monitoring Devices
      • 3.3.3.3. Clinical PSG Monitoring Devices
      • 3.3.3.4. Sleep Apnea Screening Device
      • 3.3.3.5. Nasal Flow Home Care Settings
      • 3.3.3.6. Peripheral Capillary Oxygen Saturation (SPO2)
      • 3.3.3.7. Actigraphy Monitoring Devices
  • 3.4. Market Attractiveness Analysis: Product Type
  • 3.5. Global Sleep Apnea Diagnostic Systems Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.5.3.1. Home Care Settings
      • 3.5.3.2. Hospitals
      • 3.5.3.3. Sleep Centers & Clinics
  • 3.6. Market Attractiveness Analysis: End User

4. Global Sleep Apnea Diagnostic Systems Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product Type
    • 5.3.3. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 5.5.1. Polysomnography (PSG) Devices
    • 5.5.2. Ambulatory PSG Monitoring Devices
    • 5.5.3. Clinical PSG Monitoring Devices
    • 5.5.4. Sleep Apnea Screening Device
    • 5.5.5. Nasal Flow Sensors
    • 5.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 5.5.7. Actigraphy Monitoring Devices
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.6.1. Home Care Settings
    • 5.6.2. Hospitals
    • 5.6.3. Sleep Centers & Clinics
  • 5.7. Market Attractiveness Analysis

6. Europe Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product Type
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 6.5.1. Polysomnography (PSG) Devices
    • 6.5.2. Ambulatory PSG Monitoring Devices
    • 6.5.3. Clinical PSG Monitoring Devices
    • 6.5.4. Sleep Apnea Screening Device
    • 6.5.5. Nasal Flow Sensors
    • 6.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 6.5.7. Actigraphy Monitoring Devices
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.6.1. Home Care Settings
    • 6.6.2. Hospitals
    • 6.6.3. Sleep Centers & Clinics
  • 6.7. Market Attractiveness Analysis

7. East Asia Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product Type
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 7.5.1. Polysomnography (PSG) Devices
    • 7.5.2. Ambulatory PSG Monitoring Devices
    • 7.5.3. Clinical PSG Monitoring Devices
    • 7.5.4. Sleep Apnea Screening Device
    • 7.5.5. Nasal Flow Sensors
    • 7.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 7.5.7. Actigraphy Monitoring Devices
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.6.1. Home Care Settings
    • 7.6.2. Hospitals
    • 7.6.3. Sleep Centers & Clinics
  • 7.7. Market Attractiveness Analysis

8. South Asia & Oceania Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 8.5.1. Polysomnography (PSG) Devices
    • 8.5.2. Ambulatory PSG Monitoring Devices
    • 8.5.3. Clinical PSG Monitoring Devices
    • 8.5.4. Sleep Apnea Screening Device
    • 8.5.5. Nasal Flow Sensors
    • 8.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 8.5.7. Actigraphy Monitoring Devices
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.6.1. Home Care Settings
    • 8.6.2. Hospitals
    • 8.6.3. Sleep Centers & Clinics
  • 8.7. Market Attractiveness Analysis

9. Latin America Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 9.5.1. Polysomnography (PSG) Devices
    • 9.5.2. Ambulatory PSG Monitoring Devices
    • 9.5.3. Clinical PSG Monitoring Devices
    • 9.5.4. Sleep Apnea Screening Device
    • 9.5.5. Nasal Flow Sensors
    • 9.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 9.5.7. Actigraphy Monitoring Devices
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.6.1. Home Care Settings
    • 9.6.2. Hospitals
    • 9.6.3. Sleep Centers & Clinics
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 10.5.1. Polysomnography (PSG) Devices
    • 10.5.2. Ambulatory PSG Monitoring Devices
    • 10.5.3. Clinical PSG Monitoring Devices
    • 10.5.4. Sleep Apnea Screening Device
    • 10.5.5. Nasal Flow Sensors
    • 10.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 10.5.7. Actigraphy Monitoring Devices
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.6.1. Home Care Settings
    • 10.6.2. Hospitals
    • 10.6.3. Sleep Centers & Clinics
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Ambulatory PSG Monitoring Devices
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Koninklijke Philips N.V.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Becton, Dickinson and Company
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Braedon Medical Corporation
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Advanced Brain Monitoring Inc.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. SOMNOmedics GmbH
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. ResMed Inc.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. BMC Medical Co. Ltd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Natus Medical Incorporated
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. MGC Diagnostics Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Cleveland Medical Devices Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations